Given the role of lncRNA-HOTAIR and lncRNA-CCT1 in the molecular mechanisms linked to COPD, these findings indicate that these lncRNAs may serve as novel therapeutic targets for COPD prevention [35,36]. Here, TCP1 is linked to chronic obstructive pulmonary disease.